From Lab to Patient, Garage to Market with Philip Crowley, Episode 29

In this episode of the From Lab to Patient, Garage to Market, Phil Crowley speaks with Peter Chmiel, founder & CEO of Cutting Edge Consulting...

Robotic-assisted knee replacements, especially using Stryker's Mako system, have become increasingly common in the U.S. This surge in robotic...

The General Counsel of the National Labor Relations Board ("NLRB") has issued a memo that addresses non-compete clauses in employment agreements for non-supervisory employees.

STOP! Before you sign ANY contract, watching this video could save you from extremely expensive mistakes and a great deal of future worry. Business people often make the critical error of signing a form contract, or any contract for that matter, without a thorough review by an experienced lawyer.

The Non-Disclosure Agreement (NDA), also known as a Confidentiality Agreement, is one of the most fundamental tools for protecting your company's valuable intellectual property (IP) and sensitive information

In the dynamic field of life sciences, cell and gene therapy have emerged as revolutionary forces. It redefines our approach to treating complex diseases.

Intellectual property (IP) can be a company's most valuable asset, but the term itself often causes confusion.

Pharmaceutical regulators are open to new kinds of data to support new drug applications. However, that doesn't mean that applicants can ignore the quality of that data.

Are you overlooking areas of risk that may be lurking in the contracts you have entered into?

A recent report by the Center for Research in Securities Prices indicates that the number of publicly traded companies has decreased dramatically since 1996.

Strategic Shift: CRISPR Therapeutics is pivoting from cancer drug development to cell-based medicines for autoimmune diseases.

Testing for biomarkers in patients is the state of the art in assessing effectiveness of therapies.

For young companies, intellectual property (IP) can be their most valuable asset. Yet, many inadvertently put this crucial asset at risk by making common, avoidable mistakes.

Come hear a distinguished leader of the pharmaceutical industry speak about the impact of technology on the biopharmaceutical industry.

I am so proud of the Men's Volleyball Team at my alma mater, Stevens Institute of Technology

Cybersecurity stands as the vanguard against an evolving landscape of cyber threats. Threat actors have become an omnipresent menace, targeting companies across industries.

The Patents for Humanity Program Improvement Act, H.R. 7259, was introduced on June 18th, 2020 and became law on January 5th, 2021.

Imagine a home or office building where the windows aren't just sources of light and views, but active generators of electricity.

he State of New Jersey has an affinity for life sciences innovators. That's the message of last week's meeting sponsored by the NJ Economic Development Agency ("NJEDA")...